These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 18695766)
1. Phase II trial of gemcitabine in combination with cisplatin in inoperable or advanced hepatocellular carcinoma. Chia WK; Ong S; Toh HC; Hee SW; Choo SP; Poon DY; Tay MH; Tan CK; Koo WH; Foo KF Ann Acad Med Singap; 2008 Jul; 37(7):554-8. PubMed ID: 18695766 [TBL] [Abstract][Full Text] [Related]
2. A phase II study of gemcitabine and cisplatin in patients with advanced hepatocellular carcinoma. Parikh PM; Fuloria J; Babu G; Doval DC; Awasthy BS; Pai VR; Prabhakaran PS; Benson AB Trop Gastroenterol; 2005; 26(3):115-8. PubMed ID: 16512457 [TBL] [Abstract][Full Text] [Related]
3. Gemcitabine plus oxaliplatin for patients with advanced hepatocellular carcinoma using two different schedules. Taïeb J; Bonyhay L; Golli L; Ducreux M; Boleslawski E; Tigaud JM; de Baere T; Mansourbakht T; Delgado MA; Hannoun L; Poynard T; Boige V Cancer; 2003 Dec; 98(12):2664-70. PubMed ID: 14669287 [TBL] [Abstract][Full Text] [Related]
4. Gemcitabine plus oxaliplatin (GEMOX) in patients with advanced hepatocellular carcinoma (HCC): results of a phase II study. Louafi S; Boige V; Ducreux M; Bonyhay L; Mansourbakht T; de Baere T; Asnacios A; Hannoun L; Poynard T; Taïeb J Cancer; 2007 Apr; 109(7):1384-90. PubMed ID: 17330837 [TBL] [Abstract][Full Text] [Related]
5. A clinical trial with valproic acid and hydralazine in combination with gemcitabine and cisplatin followed by doxorubicin and dacarbazine for advanced hepatocellular carcinoma. Liu YC; Su CW; Ko PS; Lee RC; Liu CJ; Huang YH; Gau JP; Liu JH Asia Pac J Clin Oncol; 2022 Feb; 18(1):19-27. PubMed ID: 32964588 [TBL] [Abstract][Full Text] [Related]
6. Gemcitabine, vinorelbine and cisplatin combination chemotherapy in advanced non-small cell lung cancer: a phase II trial. Laack E; Mende T; Dürk H; Kneba M; Dickgreber N; Welte T; Müller T; Scholtze J; Graeven U; Jasiewicz Y; Edler L; Hossfeld DK Eur J Cancer; 2002 Mar; 38(5):654-60. PubMed ID: 11916547 [TBL] [Abstract][Full Text] [Related]
7. A dose-escalation study of weekly topotecan, cisplatin, and gemcitabine front-line therapy in patients with inoperable non-small cell lung cancer. Guarino MJ; Schneider CJ; Grubbs SS; Biggs DD; Himelstein AL; Hogaboom K; Tilak S Oncologist; 2002; 7(6):509-15. PubMed ID: 12490738 [TBL] [Abstract][Full Text] [Related]
8. Prospective phase II trial of a combination of fixed dose rate infusion of gemcitabine with cisplatin and UFT as a first-line treatment in patients with advanced non-small-cell lung carcinoma. Shin SJ; Kim H; Baek JH; Ahn JJ; Jegal Y; Seo KW; Park CR; Shin JK; Jung JP; Kim JW; Cha HJ; Kwon WJ; Jeong AK; Noh YJ; Park JH; Min YJ Lung Cancer; 2008 Apr; 60(1):83-91. PubMed ID: 18006180 [TBL] [Abstract][Full Text] [Related]
10. Gemcitabine plus oxaliplatin (GEMOX) combined with cetuximab in patients with progressive advanced stage hepatocellular carcinoma: results of a multicenter phase 2 study. Asnacios A; Fartoux L; Romano O; Tesmoingt C; Louafi S S; Mansoubakht T; Artru P; Poynard T; Rosmorduc O; Hebbar M; Taieb J Cancer; 2008 Jun; 112(12):2733-9. PubMed ID: 18412149 [TBL] [Abstract][Full Text] [Related]
11. Gemcitabine and cisplatin treatment of advanced-stage non-small-cell lung cancer in patients given cisplatin on day 8. Akcali Z; Calikusu Z; Sakalli H; Ozyilkan O Tumori; 2008; 94(4):474-80. PubMed ID: 18822681 [TBL] [Abstract][Full Text] [Related]
12. Pegylated liposomal doxorubicin-based combination chemotherapy as salvage treatment in patients with advanced hepatocellular carcinoma. Poh SB; Bai LY; Chen PM Am J Clin Oncol; 2005 Dec; 28(6):540-6. PubMed ID: 16317261 [TBL] [Abstract][Full Text] [Related]
13. Feasibility of gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma patients with Child-Pugh B cirrhosis. Dhooge M; Coriat R; Mir O; Perkins G; Brezault C; Boudou-Rouquette P; Goldwasser F; Chaussade S Oncology; 2013; 84(1):32-8. PubMed ID: 23076239 [TBL] [Abstract][Full Text] [Related]
14. Phase II trial assessing the combination of gemcitabine and cisplatin in advanced non-small cell lung cancer (NSCLC). Antón A; Díaz-Fernández N; González Larriba JL; Vadell C; Masutti B; Montalar J; Barneto I; Artal A; Rosell R Lung Cancer; 1998 Nov; 22(2):139-48. PubMed ID: 10022221 [TBL] [Abstract][Full Text] [Related]
15. A randomized study comparing two different schedules of administration of cisplatin in combination with gemcitabine in advanced nonsmall cell lung carcinoma. Ricci S; Antonuzzo A; Galli L; Tibaldi C; Bertuccelli M; Lopes Pegna A; Petruzzelli S; Bonifazi V; Orlandini C; Franco Conte P Cancer; 2000 Oct; 89(8):1714-9. PubMed ID: 11042565 [TBL] [Abstract][Full Text] [Related]
16. A phase I/II study of LY900003, an antisense inhibitor of protein kinase C-alpha, in combination with cisplatin and gemcitabine in patients with advanced non-small cell lung cancer. Villalona-Calero MA; Ritch P; Figueroa JA; Otterson GA; Belt R; Dow E; George S; Leonardo J; McCachren S; Miller GL; Modiano M; Valdivieso M; Geary R; Oliver JW; Holmlund J Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6086-93. PubMed ID: 15447994 [TBL] [Abstract][Full Text] [Related]
17. Phase II study with a combination of epirubicin, cisplatin, UFT, and leucovorin in advanced hepatocellular carcinoma. Kim SJ; Seo HY; Choi JG; Sul HR; Sung HJ; Park KH; Choi IK; Oh SC; Yoon SY; Seo JH; Choi CW; Kim BS; Shin SW; Kim YH; Kim JS Cancer Chemother Pharmacol; 2006 Apr; 57(4):436-42. PubMed ID: 16049620 [TBL] [Abstract][Full Text] [Related]
18. Gemcitabine and doxorubicin for the treatment of patients with advanced hepatocellular carcinoma: a phase I-II trial. Yang TS; Wang CH; Hsieh RK; Chen JS; Fung MC Ann Oncol; 2002 Nov; 13(11):1771-8. PubMed ID: 12419750 [TBL] [Abstract][Full Text] [Related]
19. A Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer. Kim ST; Park JO; Lee J; Lee KT; Lee JK; Choi SH; Heo JS; Park YS; Kang WK; Park K Cancer; 2006 Mar; 106(6):1339-46. PubMed ID: 16475213 [TBL] [Abstract][Full Text] [Related]
20. Combination of gemcitabine and cisplatin is highly active in women with endometrial carcinoma: results of a prospective phase 2 trial. Brown J; Smith JA; Ramondetta LM; Sood AK; Ramirez PT; Coleman RL; Levenback CF; Munsell MF; Jung M; Wolf JK Cancer; 2010 Nov; 116(21):4973-9. PubMed ID: 20665499 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]